CIK 0001849296 · Non-accelerated filer<br>Emerging growth company
OKYO Pharma Ltd
Sign in to watch- Ticker
- OKYO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- Entity type
- other
- Phone
- 44 (0) 207 495 2379
- Business address
- 55 PARK LANE, LONDON, United Kingdom, W1K 1NA
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 424B5 Offering Prospectus
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 6-K Event Report of Foreign Issuer
- 424B5 Offering Prospectus
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 424B5 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 6-K Event Report of Foreign Issuer
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- F-3 Offering F-3
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
Page 4 of 16 · 312 filings